Výsledky vyhľadávania - "Antitubercular Agents adverse effects"

Long-Term Self-Administered Outpatient Parenteral Antimicrobial Therapy in the Treatment of Tuberculosis

Autori: A. Rauch N. Köhler T. T. Brehm a ďalší

Zdroj: Drugs

Predmety: Male, Adult, Antitubercular Agents, Self Administration, Female [MeSH], Adult [MeSH], Humans [MeSH], Infusions, Parenteral [MeSH], Treatment Outcome [MeSH], Retrospective Studies [MeSH], Antitubercular Agents/therapeutic use [MeSH], Tuberculosis/drug therapy [MeSH], Antitubercular Agents/adverse effects [MeSH], Outpatients [MeSH], Male [MeSH], Tuberculosis, Multidrug-Resistant/drug therapy [MeSH], Antitubercular Agents/administration, Germany [MeSH], Original Research Article, Self Administration [MeSH], Treatment Outcome, Germany, Outpatients, Tuberculosis, Multidrug-Resistant, Humans, Tuberculosis, Female, Infusions, Parenteral, Retrospective Studies

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39733377
https://repository.publisso.de/resource/frl:6517897

Genetic polymorphisms and adverse reactions to antituberculosis therapy

Autori: Gunter, Hannah M Choshi, Phuti Chimbetete, Tafadzwa a ďalší

Predmety: Antitubercular Agents - adverse effects, Antitubercular Agents - therapeutic use, Drug-Related Side Effects and Adverse Reactions - genetics, Humans, Pharmacogenetics - methods, Pharmacogenomic Testing - methods, Polymorphism, Genetic - genetics, Tuberculosis - drug therapy, Tuberculosis - genetics, Tuberculosis, Multidrug-Resistant - drug therapy, Multidrug-Resistant - genetics

Popis súboru: pdf

Relation: ispartof: Pharmacogenomics spage 207 epage 221 issue 5-6 vol 26; WOS:001512219200001; 991005791873107891; https://researchportal.murdoch.edu.au/view/delivery/61MUN_INST/12180384160007891/13180384150007891; alma:61MUN_INST/bibs/991005791873107891

Dostupnosť: https://doi.org/10.1080/14622416.2025.2509479
https://researchportal.murdoch.edu.au/esploro/outputs/journalArticle/Genetic-polymorphisms-and-adverse-reactions-to/991005791873107891
https://researchportal.murdoch.edu.au/view/delivery/61MUN_INST/12180384160007891/13180384150007891

Drug-induced hepatotoxicity and association with slow acetylation variants NAT2*5 and NAT2*6 in Cameroonian patients with tuberculosis and HIV co-infection

Autori: Cho, Frederick Nchang Achidi, Eric A Enoh, Jude Eteneneng a ďalší

Zdroj: BMC Infect Dis
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-13 (2024)

Predmety: Male, Adult, 0301 basic medicine, Pharmacogenomic Variants, Arylamine N-Acetyltransferase, Antitubercular Agents, HIV Infections, Drug-induced hepatotoxicity, Infectious and parasitic diseases, RC109-216, Polymorphism, Single Nucleotide, Young Adult, 03 medical and health sciences, Humans, Tuberculosis, Cameroon, HIV Infections/complications [MeSH], Polymorphism, Single Nucleotide [MeSH], Acetylation [MeSH], Pharmacogenomic Variants [MeSH], Tuberculosis/drug therapy [MeSH], Antitubercular Agents/adverse effects [MeSH], Male [MeSH], Pharmacogenetics, Tuberculosis/genetics [MeSH], Female [MeSH], Coinfection [MeSH], Adult [MeSH], Tuberculosis/complications [MeSH], Humans [MeSH], Co-infection, HIV, Antitubercular Agents/therapeutic use [MeSH], Middle Aged [MeSH], Chemical and Drug Induced Liver Injury/genetics [MeSH], Arylamine N-Acetyltransferase/genetics [MeSH], HIV Infections/drug therapy [MeSH], Research, Cameroon/epidemiology [MeSH], Young Adult [MeSH], 0303 health sciences, Coinfection, Acetylation, Middle Aged, 3. Good health, Female, Chemical and Drug Induced Liver Injury

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/39085767
https://doaj.org/article/45dbcd854c574d1a83341fa60c612ae4
https://pure.amsterdamumc.nl/en/publications/627e1e9d-f97c-4563-b045-ddcbdbe975e5
https://doi.org/10.1186/s12879-024-09638-w
https://repository.publisso.de/resource/frl:6519375
https://discovery-pp.ucl.ac.uk/id/eprint/10195425/

Reply to 'Therapeutic drug monitoring for isoniazid and rifampicin exposure'

Autori: Akkerman, O W Kerstjens, H A M Kingma, M a ďalší

Zdroj: Akkerman, O W, Kerstjens, H A M, Kingma, M, Bolhuis, M S & Sturkenboom, M G G 2024, 'Reply to 'Therapeutic drug monitoring for isoniazid and rifampicin exposure'', The International Journal of Tuberculosis and Lung Disease, vol. 28, no. 3, pp. 169-170. https://doi.org/10.5588/ijtld.24.0022

Predmety: Humans, Isoniazid/adverse effects, Rifampin/adverse effects, Drug Monitoring, Antitubercular Agents/adverse effects, Mycobacterium tuberculosis

Popis súboru: application/pdf

Relation: info:eu-repo/semantics/altIdentifier/pmid/38454176; info:eu-repo/semantics/altIdentifier/hdl/https://hdl.handle.net/11370/95f6247b-cdca-4292-babe-fc626b7d9041; info:eu-repo/semantics/altIdentifier/pissn/1027-3719; info:eu-repo/semantics/altIdentifier/eissn/1815-7920

Dostupnosť: https://hdl.handle.net/11370/95f6247b-cdca-4292-babe-fc626b7d9041
https://research.rug.nl/en/publications/95f6247b-cdca-4292-babe-fc626b7d9041
https://doi.org/10.5588/ijtld.24.0022
https://pure.rug.nl/ws/files/952630922/s15.pdf
https://www.scopus.com/pages/publications/85187527510

Predicting drug-induced liver injury from anti-tuberculous medications by early monitoring of liver tests

Autori: Patterson, Benjamin Abbara, Aula Collin, Simon a ďalší

Zdroj: Patterson, B, Abbara, A, Collin, S, Henderson, M, Shehata, M, Gorgui-Naguib, H, Lynn, W, Kon, O M & John, L 2021, 'Predicting drug-induced liver injury from anti-tuberculous medications by early monitoring of liver tests', Journal of Infection, vol. 82, no. 2, pp. 240-244. https://doi.org/10.1016/j.jinf.2020.09.038

Predmety: 0301 basic medicine, Antitubercular Agents/adverse effects, Chemical and Drug Induced Liver Injury/diagnosis, Tuberculosis/diagnosis, Antitubercular Agents, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, London, Humans, Tuberculosis, Chemical and Drug Induced Liver Injury, Retrospective Studies

Popis súboru: application/pdf

Prístupová URL adresa: https://research-information.bris.ac.uk/ws/files/289224945/Patterson_et_al_2021_as_accepted.pdf
https://pubmed.ncbi.nlm.nih.gov/33271167
https://researchportal.ukhsa.gov.uk/en/publications/predicting-drug-induced-liver-injury-from-anti-tuberculous-medica
https://research-information.bris.ac.uk/en/publications/predicting-drug-induced-liver-injury-from-anti-tuberculous-medica
https://researchportal.phe.gov.uk/en/publications/predicting-drug-induced-liver-injury-from-anti-tuberculous-medica
https://pubmed.ncbi.nlm.nih.gov/33271167/
https://www.sciencedirect.com/science/article/pii/S0163445320307283
https://www.ncbi.nlm.nih.gov/pubmed/33271167
https://research-information.bris.ac.uk/ws/files/289224945/Patterson_et_al_2021_as_accepted.pdf
https://hdl.handle.net/1983/2ff37ae9-9209-492b-89ef-33a1b6e45e6c

Intensified tuberculosis treatment to reduce the mortality of HIV-infected and uninfected patients with tuberculosis meningitis (INTENSE-TBM): study protocol for a phase III randomized controlled trial

Autori: Thomas Maitre Maryline Bonnet Alexandra Calmy a ďalší

Prispievatelia: Thomas Maitre Maryline Bonnet Alexandra Calmy a ďalší

Zdroj: Trials
Articles publicats en revistes (Medicina)
Dipòsit Digital de la UB
Universidad de Barcelona
Trials, Vol 23, Iss 1, Pp 1-13 (2022)

Predmety: 0301 basic medicine, Medicine (General), Alternative medicine, Epidemiology, Antitubercular Agents, HIV Infections, HIV Infections / complications, FOS: Health sciences, Aspirin / therapeutic use, Pediatrics, Study Protocol, South Africa, Clinical trials, Pathology, Multicenter Studies as Topic, HIV Infection, Diagnosis and Treatment of Spinal Infections, Internal medicine, Randomized Controlled Trials as Topic, HIV High-dose rifampicin, Human Biology & Physiology, Epidemiology and Pathogenesis of Pneumocystis Pneumonia, HIV, High-dose rifampicin, 3. Good health, Clinical trial, Infectious Diseases, Randomized controlled trial, Tuberculosis, Meningeal, HIV Infections / diagnosis, Medicine, Rifampin, Intention-to-treat analysis, HIV infections, Adult, Model organisms, Adolescent, Tuberculosi, Immunology, Àfrica, Infectious Disease, Rifapentine, 03 medical and health sciences, R5-920, Antitubercular Agents / adverse effects, Tuberculosis, Meningeal / drug therapy, Health Sciences, Humans, Tuberculosis, Aspirina, Tuberculous Meningitis, Placebo, Rifampicin, Regimen, South Africa / epidemiology, Aspirin, Latent tuberculosis, FOS: Clinical medicine, Linezolid, HIV, Mycobacterium tuberculosis, High-dose rifampicin, Tuberculous meningitis, HIV Infections / drug therapy, Treatment, Clinical Trials, Phase III as Topic, [SDV.SPEE] Life Sciences [q-bio]/Santé publique et épidémiologie, Africa, Infeccions per VIH, Surgery, Tuberculosis, Meningeal / diagnosis, Assaigs clínics

Popis súboru: application/pdf

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/36348453
https://hdl.handle.net/2445/201627
https://doaj.org/article/d5d86ff83f52483e8824561dd054f87f
https://archive-ouverte.unige.ch/unige:173269
https://doi.org/10.1186/s13063-022-06772-1
https://hal.science/hal-03903474v1
https://hal.science/hal-03903474v1/document
https://doi.org/10.1186/s13063-022-06772-1
https://discovery-pp.ucl.ac.uk/id/eprint/10158797/
http://hdl.handle.net/2445/201627

A pilot study to investigate the utility of NAT2 genotype-guided isoniazid monotherapy regimens in NAT2 slow acetylators

Autori: Hyounggyoon Yoo Kyung Sang Yu In-Jin Jang a ďalší

Prispievatelia: Hyounggyoon Yoo Kyung Sang Yu In-Jin Jang a ďalší

Zdroj: Pharmacogenetics and Genomics. 31:68-73

Predmety: Adult, Male, 0301 basic medicine, Genotype, Arylamine N-Acetyltransferase, Antitubercular Agents, Pilot Projects, Arylamine N-Acetyltransferase / genetics, Antitubercular Agents / administration & dosage, Dose-Response Relationship, 03 medical and health sciences, Antitubercular Agents / adverse effects, Latent Tuberculosis, Latent Tuberculosis / microbiology, Isoniazid, Humans, Latent Tuberculosis / drug therapy, 0303 health sciences, Dose-Response Relationship, Drug, Isoniazid / adverse effects, Isoniazid / administration & dosage, Middle Aged, Healthy Volunteers, 3. Good health, Female, Latent Tuberculosis / genetics, Drug

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/33165168
https://pubmed.ncbi.nlm.nih.gov/33165168/
http://europepmc.org/article/MED/33165168
https://www.ncbi.nlm.nih.gov/pubmed/33165168
https://snucm.elsevierpure.com/en/publications/a-pilot-study-to-investigate-the-utility-of-nat2-genotype-guided-

Inflammatory bowel perforation during immune restoration after one year of antiretroviral and antituberculous therapy in an HIV-1-infected patient: report of a case.

Autori: Guex, A.C. Bucher, H.C. Demartines, N. a ďalší

Predmety: AIDS-Related Opportunistic Infections/drug therapy, AIDS-Related Opportunistic Infections/immunology, Adult, Antiretroviral Therapy, Highly Active/adverse effects, Antitubercular Agents/adverse effects, HIV Infections/drug therapy, HIV Infections/immunology, HIV-1, Humans, Inflammation/etiology, Intestinal Perforation/etiology, Jejunal Diseases/etiology, Male, Tuberculosis, Gastrointestinal/drug therapy, Gastrointestinal/immunology

Relation: Diseases of the Colon & Rectum; https://iris.unil.ch/handle/iris/170556; serval:BIB_935FB9C48AF9; 000176830000022

Dostupnosť: https://iris.unil.ch/handle/iris/170556
https://doi.org/10.1007/s10350-004-6339-1

Treatment shortening of drug-sensitive pulmonary tuberculosis using high-dose rifampicin for 3 months after culture conversion (Hi-DoRi-3): a study protocol for an open-label randomized clinical trial

Autori: Nakwon Kwak Doosoo Jeon Youngmok Park a ďalší

Prispievatelia: Nakwon Kwak Doosoo Jeon Youngmok Park a ďalší

Zdroj: Trials
Trials, Vol 23, Iss 1, Pp 1-10 (2022)

Predmety: 0301 basic medicine, Medicine (General), Antitubercular Agents, Study Protocol, 03 medical and health sciences, Pyrazinamide / adverse effects, Pulmonary* / drug therapy, R5-920, Antitubercular Agents / adverse effects, Drug Therapy, Rifampin* / adverse effects, Isoniazid, Tuberculosis, Humans, Multicenter Studies as Topic, Tuberculosis, Pulmonary, Rifampicin, Randomized Controlled Trials as Topic, 0303 health sciences, Isoniazid / adverse effects, 16. Peace & justice, Pyrazinamide, Pulmonary* / diagnosis, Shorter regimen, 3. Good health, Treatment Outcome, Drug Therapy, Combination, Rifampin, Combination / adverse effects

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/35978342
https://doaj.org/article/eb945c4ec1694f4fb6e83e604aea77a8

Intensified tuberculosis treatment to reduce the mortality of HIV-infected and uninfected patients with tuberculosis meningitis (INTENSE-TBM): study protocol for a phase III randomized controlled trial

Autori: Maitre, Thomas Bonnet, Maryline Calmy, Alexandra a ďalší

Prispievatelia: Maitre, Thomas Bonnet, Maryline Calmy, Alexandra a ďalší

Zdroj: ISSN: 1745-6215 ; Trials, vol. 23, no. 1 (2022) 928.

Predmety: info:eu-repo/classification/ddc/616, Aspirin, HIV, High-dose rifampicin, Linezolid, Randomized controlled trial, Tuberculous meningitis, Adult, Adolescent, Humans, Tuberculosis, Meningeal / diagnosis, Meningeal / drug therapy, HIV Infections / complications, HIV Infections / diagnosis, HIV Infections / drug therapy, Rifampin, Aspirin / therapeutic use, South Africa / epidemiology, Antitubercular Agents / adverse effects, Randomized Controlled Trials as Topic, Multicenter Studies as Topic, Clinical Trials, Phase III as Topic

Relation: info:eu-repo/semantics/altIdentifier/pmid/36348453; unige:173269

Dostupnosť: https://archive-ouverte.unige.ch/unige:173269

Isoniazidinduceret toksisk hepatitis ; Isoniazid-inducedtoxic hepatitis

Autori: Kristensen, Kristina Langholz Nordholm, Anne Christine Clausen, Mette Rye a ďalší

Zdroj: Kristensen , K L , Nordholm , A C , Clausen , M R & Katzenstein , T L 2021 , ' Isoniazidinduceret toksisk hepatitis ' , Ugeskrift for Laeger , bind 183 , nr. 6 , V10200770 . < https://content.ugeskriftet.dk/sites/default/files/scientific_article_files/2021-01/v10200770_web.pdf >

Predmety: Adult, Antitubercular Agents/adverse effects, Hepatitis/drug therapy, Humans, Isoniazid/adverse effects, Latent Tuberculosis/drug therapy, Male

Popis súboru: application/pdf

Dostupnosť: https://researchprofiles.ku.dk/da/publications/a2652c33-b17a-42eb-8768-e2e4b47f10ad
https://curis.ku.dk/ws/files/337986729/v10200770_web.pdf
https://content.ugeskriftet.dk/sites/default/files/scientific_article_files/2021-01/v10200770_web.pdf

Isoniazidinduceret toksisk hepatitis

Autori: Kristensen, Kristina Langholz Nordholm, Anne Christine Clausen, Mette Rye a ďalší

Zdroj: Kristensen, K L, Nordholm, A C, Clausen, M R & Katzenstein, T L 2021, ' Isoniazidinduceret toksisk hepatitis ', Ugeskrift for Laeger, bind 183, nr. 6, V10200770 . < https://content.ugeskriftet.dk/sites/default/files/scientific_article_files/2021-01/v10200770_web.pdf >

Predmety: Adult, Male, Antitubercular Agents/adverse effects, Hepatitis/drug therapy, Humans, Isoniazid/adverse effects, Latent Tuberculosis/drug therapy, 3. Good health

Popis súboru: application/pdf

Prístupová URL adresa: https://curis.ku.dk/ws/files/337986729/v10200770_web.pdf

Treatment of Latent Tuberculosis Infection: An Updated Network Meta-analysis

Autori: Marc Lipman Dominik Zenner Marieke J. van der Werf a ďalší

Zdroj: Zenner, D, Beer, N, Harris, R J, Lipman, M CI, Stagg, H R & van der Werf, M J 2017, ' Treatment of Latent Tuberculosis Infection : An Updated Network Meta-analysis ', Annals of Internal Medicine, vol. 167, no. 4, pp. 248-255 . https://doi.org/10.7326/M17-0609

Predmety: Adult, Pyrazinamide/adverse effects, Chemical and Drug Induced Liver Injury/etiology, Antitubercular Agents/adverse effects, Network Meta-Analysis, Antitubercular Agents, CHILDREN, Isoniazid/adverse effects, General & Internal, REGIMENS, PLACEBO-CONTROLLED TRIAL, DOUBLE-BLIND, 03 medical and health sciences, 0302 clinical medicine, ANTIRETROVIRAL THERAPY, Latent Tuberculosis, General & Internal Medicine, Isoniazid, Humans, Latent Tuberculosis/drug therapy, Child, Science & Technology, RIFAPENTINE, ADULTS, RANDOMIZED CONTROLLED-TRIAL, EFFICACY, Pyrazinamide, 3. Good health, Drug Combinations, Medicine, ISONIAZID PREVENTIVE THERAPY, Rifampin/adverse effects, Chemical and Drug Induced Liver Injury, Rifampin, Life Sciences & Biomedicine

Popis súboru: application/pdf; 248 - +

Prístupová URL adresa: https://discovery.ucl.ac.uk/1558919/1/Lipman-M_treatment%20of%20latent%20tuberculosis_network%20meta-analysis.pdf
https://pubmed.ncbi.nlm.nih.gov/28761946
https://www.pure.ed.ac.uk/ws/files/75724681/Lipman_M_treatment_of_latent_tuberculosis_network_meta_analysis.pdf
https://www.ncbi.nlm.nih.gov/pubmed/28761946
http://europepmc.org/abstract/MED/28761946
https://annals.org/aim/fullarticle/2646630/treatment-latent-tuberculosis-infection-updated-network-meta-analysis
https://www.research.ed.ac.uk/en/publications/treatment-of-latent-tuberculosis-infection-an-updated-network-met
https://pubmed.ncbi.nlm.nih.gov/28761946/
https://hdl.handle.net/20.500.11820/e17e66ae-6804-4054-adec-bd7dfa20e6ef
https://www.pure.ed.ac.uk/ws/files/75724681/Lipman_M_treatment_of_latent_tuberculosis_network_meta_analysis.pdf
https://discovery-pp.ucl.ac.uk/id/eprint/1558919/

Multidrug-resistant Mycobacterium tuberculosis: a report of cosmopolitan microbial migration and an analysis of best management practices

Autori: Joean, Oana Thiele, Thea Schütz, Katharina a ďalší

Zdroj: http://lobid.org/resources/99370673697706441#!, 20(1):678.

Predmety: Mycobacterium tuberculosis/drug effects [MeSH], Tuberculosis and other mycobacterial diseases, Sudan [MeSH], Germany/epidemiology [MeSH], Antitubercular Agents/adverse effects [MeSH], Infant [MeSH], Male [MeSH], Molecular epidemiology, Sputum/microbiology [MeSH], Phenotype [MeSH], Mycobacterium tuberculosis/isolation, Microbial Sensitivity Tests [MeSH], Research Article, Transients and Migrants [MeSH], Tuberculosis, Multidrug-Resistant/epidemiology [MeSH], Female [MeSH], Case series, Adult [MeSH], Pulmonary/drug therapy [MeSH], Humans [MeSH], Pulmonary/microbiology [MeSH], Incidence [MeSH], Antitubercular Agents/therapeutic use [MeSH], Middle Aged [MeSH], Mycobacterium tuberculosis/genetics [MeSH], Multidrug-Resistant/drug therapy [MeSH], Young Adult [MeSH], Pregnancy [MeSH], Drug Resistance

Relation: https://repository.publisso.de/resource/frl:6464531; https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499973/

Dostupnosť: https://repository.publisso.de/resource/frl:6464531
https://doi.org/10.1186/s12879-020-05381-0
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7499973/

Multiple Drug Hypersensitivity Syndrome to Antituberculosis Drugs: A Case Report

Autori: Carneiro-Leão, L Gomes, I Freitas, C a ďalší

Predmety: Hipersensibilidade a Medicamentos/etiologia, Antituberculosos/efeitos adversos, Antitubercular Agents/adverse effects, Drug Hypersensitivity/etiology

Relation: http://hdl.handle.net/10400.26/32036

Dostupnosť: http://hdl.handle.net/10400.26/32036
https://doi.org/10.18176/jiaci.0446

Linezolid Trough Concentrations Correlate with Mitochondrial Toxicity-Related Adverse Events in the Treatment of Chronic Extensively Drug-Resistant Tuberculosis

Autori: Ray Y. Chen Lisa C. Goldfeder Clifton E. Barry a ďalší

Prispievatelia: Ray Y. Chen Lisa C. Goldfeder Clifton E. Barry a ďalší

Zdroj: EBioMedicine
EBioMedicine, Vol 2, Iss 11, Pp 1627-1633 (2015)

Predmety: Adult, Male, 0301 basic medicine, Medicine (General), Extensively Drug-Resistant Tuberculosis, Antitubercular Agents, Comorbidity, Linezolid/administration & dosage, Therapeutic drug monitoring, Linezolid/pharmacokinetics, Drug resistant, Polymorphism, Single Nucleotide, 03 medical and health sciences, R5-920, Risk Factors, Extensively Drug-Resistant Tuberculosis/diagnosis, Tuberculosis, Humans, rRNA, Polymorphism, 0303 health sciences, Mitochondrial toxicity, Antitubercular Agents/pharmacokinetics, Linezolid, Genes, rRNA, Antitubercular Agents/adverse effects, Single Nucleotide, Linezolid/adverse effects, Middle Aged, Mitochondrial, Mitochondria/metabolism, Mitochondria, 3. Good health, Extensively Drug-Resistant Tuberculosis/immunology, Genes, Mitochondrial, Genes, Adverse events, Extensively Drug-Resistant Tuberculosis/drug therapy, Extensively Drug-Resistant Tuberculosis/metabolism, Medicine, Female, Antitubercular Agents/administration & dosage, Drug Monitoring, Mitochondria/drug effects, Research Article

Prístupová URL adresa: http://www.ebiomedicine.com/article/S2352396415301663/pdf
https://pubmed.ncbi.nlm.nih.gov/26870788
https://doaj.org/article/7beaa75555b04827aa0e2b13b0e0cec4
https://doaj.org/article/7beaa75555b04827aa0e2b13b0e0cec4
https://www.sciencedirect.com/science/article/abs/pii/S2352396415301663
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4740314/
http://europepmc.org/articles/PMC4740314
https://yonsei.pure.elsevier.com/en/publications/linezolid-trough-concentrations-correlate-with-mitochondrial-toxi
https://core.ac.uk/display/91864933

Longitudinal analysis of retinal nerve fiber layer and ganglion cell–inner plexiform layer thickness in ethambutol-induced optic neuropathy

Autori: Jinu Han Junwon Lee Min Kwang Byun a ďalší

Prispievatelia: Jinu Han Junwon Lee Min Kwang Byun a ďalší

Zdroj: Graefe's Archive for Clinical and Experimental Ophthalmology. 253:2293-2299

Predmety: Adult, Male, Retinal Ganglion Cells, Ganglion cell–inner plexiform layer, Visual Acuity/physiology, Antitubercular Agents, Visual Acuity, Optic Nerve Diseases/chemically induced, 03 medical and health sciences, Nerve Fibers, 0302 clinical medicine, Ethambutol/adverse effects, Ethambutol-induced optic neuropathy, Optic Nerve Diseases, Tuberculosis, Humans, Prospective Studies, Retinal Ganglion Cells/pathology, Tomography, Tuberculosis, Pulmonary, Aged, Color Vision, Optic Nerve Diseases/diagnosis, Antitubercular Agents/adverse effects, Middle Aged, 3. Good health, Color Vision/physiology, Retinal nerve fiber layer, Optical Coherence, Visual Field Tests, Female, Mitochondrial optic neuropathy, Nerve Fibers/pathology, Pulmonary/drug therapy, Ethambutol, Tomography, Optical Coherence, Follow-Up Studies

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/26344730
https://link.springer.com/10.1007/s00417-015-3150-8
https://ir.ymlib.yonsei.ac.kr/handle/22282913/157088
https://europepmc.org/article/MED/26344730
https://paperity.org/p/73970338/longitudinal-analysis-of-retinal-nerve-fiber-layer-and-ganglion-cell-inner-plexiform
https://pubmed.ncbi.nlm.nih.gov/26344730/
https://link.springer.com/article/10.1007/s00417-015-3150-8

Pharmacokinetics of Rifampin and Isoniazid in Tuberculosis-HIV-Coinfected Patients Receiving Nevirapine- or Efavirenz-Based Antiretroviral Treatment

Autori: Bhatt, N B Barau, C Amin, A a ďalší

Prispievatelia: Bhatt, N B Barau, C Amin, A a ďalší

Zdroj: Antimicrobial Agents and Chemotherapy. 58:3182-3190

Predmety: Adult, Cyclopropanes, Male, 0301 basic medicine, Rifampin / adverse effects, Antitubercular Agents, HIV Infections, HIV Infections / complications, Benzoxazines / therapeutic use, Young Adult, 03 medical and health sciences, Nevirapine / therapeutic use, Rifampin / pharmacokinetics, Antitubercular Agents / adverse effects, Isoniazid, Humans, Tuberculosis, Nevirapine, Antitubercular Agents / pharmacokinetics, Antitubercular Agents / therapeutic use, Nevirapine / adverse effects, Coinfection, Tuberculosis / complications, Tuberculosis / drug therapy, Isoniazid / adverse effects, Reverse Transcriptase Inhibitors / therapeutic use, Middle Aged, Isoniazid / therapeutic use, HIV Infections / drug therapy, Benzoxazines, 3. Good health, Treatment Outcome, Benzoxazines / adverse effects, Isoniazid / pharmacokinetics, Alkynes, Reverse Transcriptase Inhibitors, Female, Rifampin / therapeutic use, Rifampin, Half-Life

Popis súboru: application/pdf

Prístupová URL adresa: https://europepmc.org/articles/pmc4068429?pdf=render
https://pubmed.ncbi.nlm.nih.gov/24663014
https://aac.asm.org/content/58/6/3182.full
https://pubmed.ncbi.nlm.nih.gov/24663014/
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4068429/
https://europepmc.org/article/MED/24663014
https://www.arca.fiocruz.br/handle/icict/10578
https://aac.asm.org/content/58/6/3182

Alcoholism and other socio-demographic risk factors for adverse TB-drug reactions and unsuccessful tuberculosis treatment – data from ten years’ observation at the Regional Centre of Pulmonology, Bydgoszcz, Poland

Autori: Anita Dąbrowska Hanna Trzcinska Grzegorz Przybylski

Zdroj: Med Sci Monit

Predmety: Male, demography, Antitubercular Agents, alcoholism - epidemiology, Poland - epidemiology, Middle Aged, 3. Good health, antitubercular agents - adverse effects, Alcoholism, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, risk factors, Humans, Tuberculosis, Female, Public Health, Poland, Treatment Failure, tuberculosis - epidemiology, treatment failure, Aged, Demography

Prístupová URL adresa: https://europepmc.org/articles/pmc3965286?pdf=render
https://pubmed.ncbi.nlm.nih.gov/24643127

Efficacy and Safety of Metronidazole for Pulmonary Multidrug-Resistant Tuberculosis

Autori: Cheon Tae Kim Véronique Dartois Wenjuan Gu a ďalší

Prispievatelia: Cheon Tae Kim Véronique Dartois Wenjuan Gu a ďalší

Zdroj: Antimicrobial Agents and Chemotherapy. 57:3903-3909

Predmety: Adult, Male, 0301 basic medicine, Peripheral Nervous System Diseases/chemically induced, Antitubercular Agents/adverse effects, Lung/pathology, Mycobacterium tuberculosis/isolation & purification, Multidrug-Resistant/drug therapy, Antitubercular Agents, Sputum/microbiology, Severity of Illness Index, Metronidazole/administration & dosage, Young Adult, 03 medical and health sciences, Double-Blind Method, Metronidazole, Tuberculosis, Multidrug-Resistant, Confidence Intervals, Tuberculosis, Humans, Metronidazole/therapeutic use, Lung, 0303 health sciences, Metronidazole/pharmacokinetics, Antitubercular Agents/pharmacokinetics, Sputum, Peripheral Nervous System Diseases, Metronidazole/adverse effects, Mycobacterium tuberculosis, 3. Good health, Treatment Outcome, Area Under Curve, Lung/microbiology, Female, Antitubercular Agents/administration & dosage, Antitubercular Agents/therapeutic use

Prístupová URL adresa: https://aac.asm.org/content/aac/57/8/3903.full.pdf
https://pubmed.ncbi.nlm.nih.gov/23733467
https://aac.asm.org/content/57/8/3903
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3719751/
https://www.ncbi.nlm.nih.gov/pubmed/23733467
https://pubmed.ncbi.nlm.nih.gov/23733467/
https://europepmc.org/abstract/MED/23733467